Uwell Biopharma, Inc. (TPEX:7902)
Taiwan · Delayed Price · Currency is TWD 46.00
-3.95 (-7.91%)
At close: Feb 26, 2026
Uwell Biopharma Revenue
Uwell Biopharma had revenue of 450.00K TWD in the twelve months ending June 30, 2025. In the year 2024, Uwell Biopharma had annual revenue of 450.00K.
Revenue
450.00K
Revenue Growth
n/a
P/S Ratio
19,888.89
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 450.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| QST International | 11.84B |
| Forcecon Technology | 9.22B |
| Gamania Digital Entertainment | 9.12B |
| Netronix | 8.22B |
| Lanner Electronics | 7.28B |
| Axiomtek | 7.02B |
| Genesys Logic | 4.01B |
| Hsin Tai Gas | 3.10B |